Investigating the positive relationship between tumor-infiltrating lymphocytes and trastuzumab therapy

Immunotherapy. 2014;6(7):803-5. doi: 10.2217/imt.14.60.
No abstract available

Keywords: HER2; adjuvant; anti-PD-1; breast cancer; trastuzumab; tumor-infiltrating lymphocytes.

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms* / drug therapy
  • Breast Neoplasms* / immunology
  • Breast Neoplasms* / pathology
  • Female
  • Humans
  • Immunity, Cellular
  • Lymphocytes* / immunology
  • Lymphocytes* / pathology
  • Portraits as Topic
  • Trastuzumab

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Trastuzumab